Previous Close | 114.40 |
Open | 0.00 |
Bid | 0.00 x N/A |
Ask | 0.00 x N/A |
Day's Range | 0.00 - 0.00 |
52 Week Range | |
Volume | |
Avg. Volume | 105,120 |
Market Cap | N/A |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | Jun 10, 2024 - Jun 14, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...
6th Clinical Trial Supply Forum -- Helping sponsors and CROs meet the challenges of complex and global clinical trial studies, Oracle today announced new capabilities in Oracle Clinical One Randomization and Trial Supply Management (RTSM). With new enhancements for use, access, and regionalization, Clinical One RTSM users can address dynamic, country-specific regulations and requirements, and gain speed, reliability, and transparency of trials from commencement to closeout.
Utilities are turning to modern digital technology as they face growing pressure to maintain grid reliability, improve customer service, and balance decarbonization goals. The annual Oracle Energy and Water Awards recognize some of the most progressive utilities in the world tackling these and other challenges. The 2024 winners include Exelon, JXN Water, and Portland General Electric.